Multifaceted approach to reducing unnecessary red blood cell utilization

Healthcare

Volumn 3, Issue 2, 2015, Pages 67-73

  Abbett, Sarah K ^a   Kaufman, Richard M ^b   Gustafson, Michael ^c   Greenberg, Jeffrey O ^b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Brigham and Women's/Faulkner Hospitals   (United States)

Author keywords

Appropriateness; Decision support; Performance improvement; Transfusions; Value

Indexed keywords

ARTICLE; CLINICAL EDUCATION; DECISION SUPPORT SYSTEM; ERYTHROCYTE TRANSFUSION; FUNDING; HEALTH CARE POLICY; HUMAN; MEDICAL INFORMATION SYSTEM; PERSONNEL MANAGEMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION; BLOOD; COOPERATION; ERYTHROCYTE; LEADERSHIP; ORGANIZATION; ORGANIZATIONAL CULTURE; TOTAL QUALITY MANAGEMENT; UNITED STATES;

BLOOD; COOPERATIVE BEHAVIOR; DECISION MAKING, ORGANIZATIONAL; ERYTHROCYTES; HUMANS; LEADERSHIP; ORGANIZATIONAL CULTURE; ORGANIZATIONAL INNOVATION; QUALITY IMPROVEMENT; TOTAL QUALITY MANAGEMENT; UNITED STATES;

EID: 84943162378     PISSN: 22130764     EISSN: 22130772     Source Type: Journal    
DOI: 10.1016/j.hjdsi.2014.07.003     Document Type: Article

References (47)

1. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. J Am Med Assoc. 2002;287:1968-1971.
2. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. J Am Med Assoc. 2003;289:959-962.
3. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest. 2005;127:295-307.
4. Perkins HA, Busch MP. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion. 2010;50:2080-2099.
5. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood. 2009;113:3406-3417.
6. Whalen J. Boston hospitals need your blood donations. Boston Mag. 2013 ( Accessed 18.12.13).
7. Goudnough LT, Shieh L, Hadhazy E, Cheng N, Khari P, Maggio P. Improved blood utilization using real-time clinical decision support. Transfusion. 2013, http://dx.doi.org/10.1111/trf.12445 (Epub ahead of print).
8. Brigham and Women's Hospital. Discovery and innovation: working together to provide superior healthcare, the strategic commitments of Brigham and Women's and Faulkner Hospitals. ; 2012. Accessed 18.12.13.
9. Office of the National Coordinator for Health Information Technology. Profile Brigham and Women's Hospital. . Accessed 20.12.13.
10. Rothschild JM, McGurk S, Honour M, et al. Assessment of education and computerized decision support interventions for improving transfusion practice. Transfusion. 2007;47:228-239.
11. Kaiser Family Foundation. Focus on health reform: Massachusetts health care reform: six years later. ; 2012 Accessed 20.12.13.
12. Massachusetts Campaign for Single Payer Health Care. Report: Massachusetts health reform in practice. Accessed 20.12.13.
13. Governor Deval Patrick. Implementing health care cost containment. Accessed 26.12.13.
14. Governor Deval Patrick. The next phase of Massachusetts health care reform. Accessed 26.12.13.
15. Porter ME. A strategy for health care reform-toward a value-based system. N Engl J Med. 2009;361:109-112.
16. Porter ME. What is value in health care? N Engl J Med. 2010;363:2477-2481.
17. Sherwood MW, Wang Y, Curtis JP, Peterson ED, Rao SV. Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention. J Am Med Assoc. 2014;311:836-843.
18. Browne JA, Adib F, Brown TE, NovicoffWM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty. 2013;28:34-37.
19. Chen AF, Klatt BA, Yazer MH, Waters JH. Blood utilization after primary total joint arthroplasty in a large hospital network. HSS J. 2013;9:123-128.
20. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340: 409-417.
21. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion strategy in high-risk patients after hip surgery. N Engl J Med. 2011;365:2453-2462.
22. Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356:1609-1619.
23. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157:49-58.
24. Hébert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med. 2001;29: 227-234.
25. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. J Am Med Assoc. 2002;288:1499-1507.
26. Bracey AW, Radovancevic R, Riggs SA, et al. Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion. 1999;39:1070-1077.
27. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345: 1230-1236.
28. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. J Am Med Assoc. 2004;292:1555-1562.
29. Carson JL, Terrin ML, Chaitman BR, et al. Transfusion trigger trial for functional outcomes in cardiovascular patients undergoing surgical hip fracture repair (FOCUS). Transfusion. 2006;46:2192-2206.
30. Hajjar LA, Vincent J-L, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. J Am Med Assoc. 2010;304: 1559-1567.
31. Ferraris VA, Brown JR, Despotis GJ, et al. Update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944-982.
32. Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer. 1999;86:1528-1536.
33. Mayr NA, Wang JZ, Zhang D, et al. Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer. Int J Radiat Oncol Biol Phys. 2009;5:1513-1521.
34. Thomas G, Ali S, Hoebers FJ, et al. Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer. Gynecol Oncol. 2008;108:317-325.
35. Broberg CS, Jayaweera AR, Diller GP, et al. Seeking optimal relation between oxygen saturation and hemoglobin concentration in adults with cyanosis from congenital heart disease. Am J Cardiol. 2011;107:595-599.
36. Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol. 2004;97(Suppl. 1):S109-S115.
37. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;52:e143-e263.
38. Barr PJ, Bailie KE. Transfusion thresholds in FOCUS. N Engl J Med. 2011;365: 2532-2533.
39. Solomon RA, Fink ME, Lennihan L. Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery. 1988;23:699-704.
40. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg. 2004;101:1-7.
41. Naidech AM, Jovanovic B, Wartenberg KE, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med. 2007;35:2283-2289.
42. Naidech AM, Shaibani A, Garg RK, et al. Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care. 2010;13: 313-320.
43. Le Roux PD. Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Anemia and transfusion after subarachnoid hemorrhage. Neurocrit Care. 2011;15:342-353.
44. Kramer AH, Diringer MN, Suarez JL, Naidech AM, Macdonald LR, Le Roux PD. Red blood cell transfusion in patients with subarachnoid hemorrhage: a multidisciplinary North American survey. Crit Care. 2011;15:R30.
45. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042.
46. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001;39:II2-II45.
47. Grol R. Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction. J Am Med Assoc. 2001;286:2578-2585.